TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs12926788
log Bayes Factor = 0.00831407
Chromosome 16   position 24,879,963  (GRCh37) Explore rs12926788 on Ensembl!
Variant rs12926788 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
F31 Bipolar affective disorder
0.000 0.886 0.114
F31.1 Bipolar affective disorder, current episode manic without psychotic symptoms
0.000 0.887 0.113
F31.3 Bipolar affective disorder, current episode mild or moderate depression
0.000 0.889 0.111
F31.0 Bipolar affective disorder, current episode hypomanic
0.000 0.893 0.107
F31.5 Bipolar affective disorder, current episode severe depression with psychotic symptoms
0.000 0.904 0.096
F31.6 Bipolar affective disorder, current episode mixed
0.000 0.906 0.094
F31.7 Bipolar affective disorder, currently in remission
0.000 0.907 0.093
F31.8 Other bipolar affective disorders
0.000 0.918 0.082
F31.2 Bipolar affective disorder, current episode manic with psychotic symptoms
0.000 0.920 0.080
F31.4 Bipolar affective disorder, current episode severe depression without psychotic symptoms
0.000 0.921 0.079
F31.9 Bipolar affective disorder, unspecified
0.000 0.942 0.058
F30-F39 Mood [affective] disorders
0.000 0.959 0.041
F32.2 Severe depressive episode without psychotic symptoms
0.000 0.966 0.034
F32 Depressive episode
0.000 0.966 0.034
F34 Persistent mood [affective] disorders
0.000 0.968 0.032
F38 Other mood [affective] disorders
0.000 0.970 0.030
F30 Manic episode
0.000 0.973 0.027
F32.3 Severe depressive episode with psychotic symptoms
0.000 0.975 0.025
H18.8 Other specified disorders of cornea
0.025 0.975 0.000
F32.0 Mild depressive episode
0.000 0.975 0.025
F34.1 Dysthymia
0.000 0.975 0.025
H20.9 Iridocyclitis, unspecified
0.025 0.975 0.000
F32.8 Other depressive episodes
0.000 0.976 0.024
F33 Recurrent depressive disorder
0.000 0.977 0.023
F34.9 Persistent mood [affective] disorder, unspecified
0.000 0.977 0.023
F34.8 Other persistent mood [affective] disorders
0.000 0.977 0.023
F34.0 Cyclothymia
0.000 0.977 0.023
F39 Unspecified mood [affective] disorder
0.000 0.977 0.022
H18 Other disorders of cornea
0.022 0.978 0.000
F30.0 Hypomania
0.000 0.978 0.022
F38.8 Other specified mood [affective] disorders
0.000 0.978 0.021
F38.1 Other recurrent mood [affective] disorders
0.000 0.978 0.021
F38.0 Other single mood [affective] disorders
0.000 0.978 0.021
H20 Iridocyclitis
0.021 0.978 0.000
H18.4 Corneal degeneration
0.021 0.979 0.000
F33.0 Recurrent depressive disorder, current episode mild
0.000 0.980 0.020
F30.8 Other manic episodes
0.000 0.980 0.020
F30.1 Mania without psychotic symptoms
0.000 0.980 0.020
T43.5 Other and unspecified antipsychotics and neuroleptics
0.000 0.980 0.020
F32.1 Moderate depressive episode
0.000 0.981 0.019
H15-H22 Disorders of sclera, cornea, iris and ciliary body
0.019 0.981 0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.000 0.982 0.018
F30.9 Manic episode, unspecified
0.000 0.982 0.018
F33.1 Recurrent depressive disorder, current episode moderate
0.000 0.982 0.018
T43.2 Other and unspecified antidepressants
0.000 0.982 0.018
H20.1 Chronic iridocyclitis
0.018 0.982 0.000
H20.8 Other iridocyclitis
0.017 0.983 0.000
F33.8 Other recurrent depressive disorders
0.000 0.983 0.017
F33.4 Recurrent depressive disorder, currently in remission
0.000 0.983 0.017
H18.7 Other corneal deformities
0.016 0.984 0.000
H18.3 Changes in corneal membranes
0.016 0.984 0.000
H18.0 Corneal pigmentations and deposits
0.016 0.984 0.000
H18.9 Disorder of cornea, unspecified
0.016 0.984 0.000
T43.3 Phenothiazine antipsychotics and neuroleptics
0.000 0.984 0.016
H20.2 Lens-induced iridocyclitis
0.016 0.984 0.000
H18.5 Hereditary corneal dystrophies
0.016 0.984 0.000
H18.1 Bullous keratopathy
0.015 0.984 0.000
H18.6 Keratoconus
0.015 0.985 0.000
F30.2 Mania with psychotic symptoms
0.000 0.985 0.014
T43.4 Butyrophenone and thioxanthene neuroleptics
0.000 0.986 0.014
T43.0 Tricyclic and tetracyclic antidepressants
0.000 0.986 0.014
H22 Disorders of iris and ciliary body in diseases classified elsewhere
0.014 0.986 0.000
H16 Keratitis
0.014 0.986 0.000
F33.9 Recurrent depressive disorder, unspecified
0.000 0.986 0.014
T43.9 Psychotropic drug, unspecified
0.000 0.986 0.013
T43.8 Other psychotropic drugs, not elsewhere classified
0.000 0.986 0.013
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.000 0.986 0.013
F33.3 Recurrent depressive disorder, current episode severe with psychotic symptoms
0.000 0.987 0.013
H17 Corneal scars and opacities
0.013 0.987 0.000
H19 Disorders of sclera and cornea in diseases classified elsewhere
0.013 0.987 0.000
H21 Other disorders of iris and ciliary body
0.013 0.987 0.000
H15 Disorders of sclera
0.012 0.988 0.000
F33.2 Recurrent depressive disorder, current episode severe without psychotic symptoms
0.000 0.988 0.012
H18.2 Other corneal oedema
0.012 0.988 0.000
H16.8 Other keratitis
0.011 0.989 0.000
T43.6 Psychostimulants with abuse potential
0.000 0.989 0.011
R52.9 Pain, unspecified
0.000 0.989 0.011
R52.0 Acute pain
0.000 0.989 0.011
T50.9 Other and unspecified drugs, medicaments and biological substances
0.000 0.989 0.011
R52 Pain, not elsewhere classified
0.000 0.989 0.011
H16.9 Keratitis, unspecified
0.010 0.990 0.000
M16.0 Primary coxarthrosis, bilateral
0.000 0.990 0.010
H22.8 Other disorders of iris and ciliary body in diseases classified elsewhere
0.010 0.990 0.000
H22.0 Iridocyclitis in infectious and parasitic diseases classified elsewhere
0.010 0.990 0.000
H22.1 Iridocyclitis in other diseases classified elsewhere
0.010 0.990 0.000
H16.4 Corneal neovascularisation
0.010 0.990 0.000
H16.3 Interstitial and deep keratitis
0.010 0.990 0.000
Chapter V Mental and behavioural disorders
0.000 0.990 0.010
H21.9 Disorder of iris and ciliary body, unspecified
0.010 0.990 0.000
H20.0 Acute and subacute iridocyclitis
0.010 0.990 0.000
H17.8 Other corneal scars and opacities
0.010 0.990 0.000
H16.2 Keratoconjunctivitis
0.010 0.990 0.000
H16.1 Other superficial keratitis without conjunctivitis
0.010 0.990 0.000
H21.4 Pupillary membranes
0.010 0.990 0.000
H17.1 Other central corneal opacity
0.010 0.990 0.000
H17.0 Adherent leukoma
0.010 0.990 0.000
H19.8 Other disorders of sclera and cornea in diseases classified elsewhere
0.010 0.990 0.000
H19.2 Keratitis and keratoconjunctivitis in other infectious and parasitic diseases classified elsewhere
0.010 0.990 0.000
H19.0 Scleritis and episcleritis in diseases classified elsewhere
0.010 0.990 0.000
H21.0 Hyphaema
0.010 0.990 0.000
H21.1 Other vascular disorders of iris and ciliary body
0.010 0.990 0.000
H21.3 Cyst of iris, ciliary body and anterior chamber
0.009 0.990 0.000
H19.3 Keratitis and keratoconjunctivitis in other diseases classified elsewhere
0.009 0.991 0.000
N18.4 Chronic kidney disease, stage 4
0.000 0.991 0.009
H21.2 Degeneration of iris and ciliary body
0.009 0.991 0.000
H19.1 Herpesviral keratitis and keratoconjunctivitis
0.009 0.991 0.000
R52.2 Other chronic pain
0.000 0.991 0.009
R52.1 Chronic intractable pain
0.000 0.991 0.009
H15.9 Disorder of sclera, unspecified
0.009 0.991 0.000
H15.1 Episcleritis
0.009 0.991 0.000
H15.0 Scleritis
0.009 0.991 0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.000 0.991 0.009
F40-F48 Neurotic, stress-related and somatoform disorders
0.000 0.991 0.009
H21.8 Other specified disorders of iris and ciliary body
0.009 0.991 0.000
T36-T50 Poisoning by drugs, medicaments and biological substances
0.000 0.991 0.009
H17.9 Corneal scar and opacity, unspecified
0.008 0.991 0.000
H16.0 Corneal ulcer
0.008 0.991 0.000
F70-F79 Mental retardation
0.000 0.991 0.008
H54.9 Unspecified visual impairment (binocular)
0.000 0.991 0.009
F42 Obsessive-compulsive disorder
0.000 0.992 0.008
F42.9 Obsessive-compulsive disorder, unspecified
0.000 0.992 0.008
H21.5 Other adhesions and disruptions of iris and ciliary body
0.008 0.992 0.000
F80-F89 Disorders of psychological development
0.000 0.992 0.008
F43 Reaction to severe stress, and adjustment disorders
0.000 0.992 0.008
F43.1 Posttraumatic stress disorder
0.000 0.992 0.008
F60-F69 Disorders of adult personality and behaviour
0.000 0.992 0.008
F90-F98 Behavioural and emotional disorders with onset usually occurring in childhood and adolescence
0.000 0.992 0.007
H15.8 Other disorders of sclera
0.007 0.993 0.000
F99-F99 Unspecified mental disorder
0.000 0.993 0.007
F79 Unspecified mental retardation
0.000 0.993 0.007
F40 Phobic anxiety disorders
0.000 0.993 0.007
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.000 0.993 0.007
S06.00 Concussion (without open intracranial wound)
0.007 0.993 0.000
C15.5 Lower third of oesophagus
0.007 0.993 0.000
F48 Other neurotic disorders
0.000 0.993 0.007
F80 Specific developmental disorders of speech and language
0.000 0.993 0.007
F84 Pervasive developmental disorders
0.000 0.993 0.007
F43.9 Reaction to severe stress, unspecified
0.000 0.993 0.007
Y40.0 Penicillins
0.007 0.993 0.000
F40.2 Specific (isolated) phobias
0.000 0.993 0.007
T50.7 Analeptics and opioid receptor antagonists
0.000 0.993 0.007
T50.5 Appetite depressants
0.000 0.993 0.007
T50.3 Electrolytic, caloric and water-balance agents
0.000 0.993 0.007
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.000 0.993 0.007
T50.1 Loop [high-ceiling] diuretics
0.000 0.993 0.007
T50.0 Mineralocorticoids and their antagonists
0.000 0.993 0.007
F79.9 Unspecified mental retardation (Without mention of impairment of behaviour)
0.000 0.993 0.007
T50.8 Diagnostic agents
0.000 0.993 0.007
F44 Dissociative [conversion] disorders
0.000 0.993 0.006
F69 Unspecified disorder of adult personality and behaviour
0.000 0.993 0.006
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.000 0.993 0.006
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.000 0.993 0.006
T41 Poisoning by anaesthetics and therapeutic gases
0.000 0.993 0.006
F50-F59 Behavioural syndromes associated with physiological disturbances and physical factors
0.000 0.994 0.006
T50.6 Antidotes and chelating agents, not elsewhere classified
0.000 0.994 0.006
F78 Other mental retardation
0.000 0.994 0.006
F73 Profound mental retardation
0.000 0.994 0.006
F72 Severe mental retardation
0.000 0.994 0.006
F71 Moderate mental retardation
0.000 0.994 0.006
F70 Mild mental retardation
0.000 0.994 0.006
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.000 0.994 0.006
F42.8 Other obsessive-compulsive disorders
0.000 0.994 0.006
F42.2 Mixed obsessional thoughts and acts
0.000 0.994 0.006
F42.1 Predominantly compulsive acts [obsessional rituals]
0.000 0.994 0.006
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.000 0.994 0.006
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.000 0.994 0.006
F89 Unspecified disorder of psychological development
0.000 0.994 0.006
F88 Other disorders of psychological development
0.000 0.994 0.006
F83 Mixed specific developmental disorders
0.000 0.994 0.006
F82 Specific developmental disorder of motor function
0.000 0.994 0.006
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.000 0.994 0.006
T39.0 Salicylates
0.000 0.994 0.006
F43.8 Other reactions to severe stress
0.000 0.994 0.006
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.000 0.994 0.006
F42.0 Predominantly obsessional thoughts or ruminations
0.000 0.994 0.006
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.000 0.994 0.006
F80.1 Expressive language disorder
0.000 0.994 0.006
T42.1 Iminostilbenes
0.000 0.994 0.006
T46 Poisoning by agents primarily affecting the cardiovascular system
0.000 0.994 0.006
F64 Gender identity disorders
0.000 0.994 0.006
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.000 0.994 0.006
T36 Poisoning by systemic antibiotics
0.000 0.994 0.006
R41.8 Other and unspecified symptoms and signs involving cognitive functions and awareness
0.006 0.994 0.000
F68 Other disorders of adult personality and behaviour
0.000 0.994 0.006
F66 Psychological and behavioural disorders associated with sexual development and orientation
0.000 0.994 0.006
F65 Disorders of sexual preference
0.000 0.994 0.006
F63 Habit and impulse disorders
0.000 0.994 0.006
F62 Enduring personality changes, not attributable to brain damage and disease
0.000 0.994 0.006
F61 Mixed and other personality disorders
0.000 0.994 0.006
F84.5 Asperger's syndrome
0.000 0.994 0.006
F00.9 Dementia in Alzheimer's disease, unspecified
0.000 0.994 0.006
F81 Specific developmental disorders of scholastic skills
0.000 0.994 0.006
F98 Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence
0.000 0.994 0.005
F95 Tic disorders
0.000 0.994 0.005
F94 Disorders of social functioning with onset specific to childhood and adolescence
0.000 0.994 0.005
F93 Emotional disorders with onset specific to childhood
0.000 0.994 0.005
F92 Mixed disorders of conduct and emotions
0.000 0.994 0.005
F91 Conduct disorders
0.000 0.994 0.005
F90 Hyperkinetic disorders
0.000 0.994 0.005
M43.16 Spondylolisthesis (Lumbar region)
0.000 0.994 0.006
K55.0 Acute vascular disorders of intestine
0.006 0.994 0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.000 0.994 0.006
I05 Rheumatic mitral valve diseases
0.006 0.994 0.000
F40.9 Phobic anxiety disorder, unspecified
0.000 0.994 0.005
F43.2 Adjustment disorders
0.000 0.994 0.006
F48.0 Neurasthenia
0.000 0.994 0.005
F79.8 Unspecified mental retardation (Other impairments of behaviour)
0.000 0.994 0.005
F79.1 Unspecified mental retardation (Significant impairment of behaviour requiring attention or treatment)
0.000 0.994 0.005
F79.0 Unspecified mental retardation (With the statement of no, or minimal, impairment of behaviour)
0.000 0.994 0.005
I05.9 Mitral valve disease, unspecified
0.006 0.994 0.000
F40.8 Other phobic anxiety disorders
0.000 0.994 0.005
F40.1 Social phobias
0.000 0.994 0.005
F99 Mental disorder, not otherwise specified
0.000 0.994 0.005
T39.4 Antirheumatics, not elsewhere classified
0.000 0.994 0.005
T39.2 Pyrazolone derivatives
0.000 0.994 0.005
I05.0 Mitral stenosis
0.005 0.995 0.000
S06.0 Concussion
0.005 0.995 0.000
T50.4 Drugs affecting uric acid metabolism
0.000 0.995 0.005
F44.5 Dissociative convulsions
0.000 0.995 0.005
F43.0 Acute stress reaction
0.000 0.995 0.005
F48.9 Neurotic disorder, unspecified
0.000 0.995 0.005
F48.8 Other specified neurotic disorders
0.000 0.995 0.005
F48.1 Depersonalisation-derealisation syndrome
0.000 0.995 0.005
F80.9 Developmental disorder of speech and language, unspecified
0.000 0.995 0.005
F80.8 Other developmental disorders of speech and language
0.000 0.995 0.005
F80.3 Acquired aphasia with epilepsy [Landau-Kleffner]
0.000 0.995 0.005
F80.2 Receptive language disorder
0.000 0.995 0.005
F80.0 Specific speech articulation disorder
0.000 0.995 0.005
T45.5 Anticoagulants
0.000 0.995 0.005
F00 Dementia in Alzheimer's disease
0.000 0.995 0.005
F84.9 Pervasive developmental disorder, unspecified
0.000 0.995 0.005
F84.8 Other pervasive developmental disorders
0.000 0.995 0.005
F84.4 Overactive disorder associated with mental retardation and stereotyped movements
0.000 0.995 0.005
F84.3 Other childhood disintegrative disorder
0.000 0.995 0.005
F84.2 Rett's syndrome
0.000 0.995 0.005
F84.1 Atypical autism
0.000 0.995 0.005
F84.0 Childhood autism
0.000 0.995 0.005
H54.4 Blindness, one eye
0.000 0.995 0.005
I05.1 Rheumatic mitral insufficiency
0.005 0.995 0.000
F10.4 Withdrawal state with delirium
0.000 0.995 0.005
M54.36 Sciatica (Lumbar region)
0.005 0.995 0.000
H54 Blindness and low vision
0.000 0.995 0.005
F44.4 Dissociative motor disorders
0.000 0.995 0.005
N18.5 Chronic kidney disease, stage 5
0.000 0.995 0.005
F44.8 Other dissociative [conversion] disorders
0.000 0.995 0.005
F44.7 Mixed dissociative [conversion] disorders
0.000 0.995 0.005
F44.6 Dissociative anaesthesia and sensory loss
0.000 0.995 0.005
F44.3 Trance and possession disorders
0.000 0.995 0.005
F44.2 Dissociative stupor
0.000 0.995 0.005
F44.1 Dissociative fugue
0.000 0.995 0.005
F44.0 Dissociative amnesia
0.000 0.995 0.005
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.000 0.995 0.005
T42.0 Hydantoin derivatives
0.000 0.995 0.005
T41.5 Therapeutic gases
0.000 0.995 0.005
T41.4 Anaesthetic, unspecified
0.000 0.995 0.005
T41.3 Local anaesthetics
0.000 0.995 0.005
T41.2 Other and unspecified general anaesthetics
0.000 0.995 0.005
T41.1 Intravenous anaesthetics
0.000 0.995 0.005
T41.0 Inhaled anaesthetics
0.000 0.995 0.005
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.000 0.995 0.005
T48.6 Antiasthmatics, not elsewhere classified
0.000 0.995 0.005
T48.5 Anti-common-cold drugs
0.000 0.995 0.005
T48.4 Expectorants
0.000 0.995 0.005
T48.3 Antitussives
0.000 0.995 0.005
T48.2 Other and unspecified agents primarily acting on muscles
0.000 0.995 0.005
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.000 0.995 0.005
T48.0 Oxytocic drugs
0.000 0.995 0.005
T49.9 Topical agent, unspecified
0.000 0.995 0.005
T49.8 Other topical agents
0.000 0.995 0.005
T49.7 Dental drugs, topically applied
0.000 0.995 0.005
T49.6 Otorhinolaryngological drugs and preparations
0.000 0.995 0.005
T49.5 Ophthalmological drugs and preparations
0.000 0.995 0.005
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.000 0.995 0.005
T49.3 Emollients, demulcents and protectants
0.000 0.995 0.005
T49.2 Local astringents and local detergents
0.000 0.995 0.005
T49.1 Antipruritics
0.000 0.995 0.005
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.000 0.995 0.005
T46.1 Calcium-channel blockers
0.000 0.995 0.005
F53 Mental and behavioural disorders associated with the puerperium, not elsewhere classified
0.000 0.995 0.005
F51 Nonorganic sleep disorders
0.000 0.995 0.005
F50 Eating disorders
0.000 0.995 0.005
F59 Unspecified behavioural syndromes associated with physiological disturbances and physical factors
0.000 0.995 0.005
F55 Abuse of non-dependence-producing substances
0.000 0.995 0.005
F54 Psychological and behavioural factors associated with disorders or diseases classified elsewhere
0.000 0.995 0.005
F00-F09 Organic, including symptomatic, mental disorders
0.000 0.995 0.005
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.000 0.995 0.005
F70.9 Mild mental retardation (Without mention of impairment of behaviour)
0.000 0.995 0.005
F70.8 Mild mental retardation (Other impairments of behaviour)
0.000 0.995 0.005
F70.1 Mild mental retardation (Significant impairment of behaviour requiring attention or treatment)
0.000 0.995 0.005
F70.0 Mild mental retardation (With the statement of no, or minimal, impairment of behaviour)
0.000 0.995 0.005
F71.9 Moderate mental retardation (Without mention of impairment of behaviour)
0.000 0.995 0.005
F71.8 Moderate mental retardation (Other impairments of behaviour)
0.000 0.995 0.005
F71.1 Moderate mental retardation (Significant impairment of behaviour requiring attention or treatment)
0.000 0.995 0.005
F71.0 Moderate mental retardation (With the statement of no, or minimal, impairment of behaviour)
0.000 0.995 0.005
F72.9 Severe mental retardation (Without mention of impairment of behaviour)
0.000 0.995 0.005
F72.8 Severe mental retardation (Other impairments of behaviour)
0.000 0.995 0.005
F72.1 Severe mental retardation (Significant impairment of behaviour requiring attention or treatment)
0.000 0.995 0.005
F72.0 Severe mental retardation (With the statement of no, or minimal, impairment of behaviour)
0.000 0.995 0.005
F73.9 Profound mental retardation (Without mention of impairment of behaviour)
0.000 0.995 0.005
F73.8 Profound mental retardation (Other impairments of behaviour)
0.000 0.995 0.005
F73.1 Profound mental retardation (Significant impairment of behaviour requiring attention or treatment)
0.000 0.995 0.005
F73.0 Profound mental retardation (With the statement of no, or minimal, impairment of behaviour)
0.000 0.995 0.005
F78.9 Other mental retardation (Without mention of impairment of behaviour)
0.000 0.995 0.005
F78.8 Other mental retardation (Other impairments of behaviour)
0.000 0.995 0.005
F78.1 Other mental retardation (Significant impairment of behaviour requiring attention or treatment)
0.000 0.995 0.005
F78.0 Other mental retardation (With the statement of no, or minimal, impairment of behaviour)
0.000 0.995 0.005
I05.2 Mitral stenosis with insufficiency
0.005 0.995 0.000
F20-F29 Schizophrenia, schizotypal and delusional disorders
0.000 0.995 0.005
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.000 0.995 0.005
T42.5 Mixed antiepileptics, not elsewhere classified
0.000 0.995 0.005
T42.3 Barbiturates
0.000 0.995 0.005
T42.2 Succinimides and oxazolidinediones
0.000 0.995 0.005
T42.4 Benzodiazepines
0.000 0.995 0.005
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.000 0.995 0.005
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.000 0.995 0.005
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.995 0.005
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.000 0.995 0.005
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.000 0.995 0.005
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.000 0.995 0.005
T44.1 Other parasympathomimetics [cholinergics]
0.000 0.995 0.005
T44.0 Anticholinesterase agents
0.000 0.995 0.005
T45.9 Primarily systemic and haematological agent, unspecified
0.000 0.995 0.005
T45.8 Other primarily systemic and haematological agents
0.000 0.995 0.005
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.000 0.995 0.005
T45.6 Fibrinolysis-affecting drugs
0.000 0.995 0.005
T45.4 Iron and its compounds
0.000 0.995 0.005
T45.3 Enzymes, not elsewhere classified
0.000 0.995 0.005
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.000 0.995 0.005
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.000 0.995 0.004
T47.8 Other agents primarily affecting the gastro-intestinal system
0.000 0.995 0.004
T47.7 Emetics
0.000 0.995 0.004
T47.6 Antidiarrhoeal drugs
0.000 0.995 0.004
T47.5 Digestants
0.000 0.995 0.004
T47.4 Other laxatives
0.000 0.995 0.004
T47.3 Saline and osmotic laxatives
0.000 0.995 0.004
T47.2 Stimulant laxatives
0.000 0.995 0.004
T47.0 Histamine H(2)-receptor antagonists
0.000 0.995 0.004
M54.16 Radiculopathy (Lumbar region)
0.005 0.995 0.000
T46.5 Other antihypertensive drugs, not elsewhere classified
0.000 0.995 0.005
F10-F19 Mental and behavioural disorders due to psychoactive substance use
0.000 0.995 0.005
N18.9 Chronic renal failure, unspecified
0.000 0.995 0.005
T45.1 Antineoplastic and immunosuppressive drugs
0.000 0.995 0.004
F60 Specific personality disorders
0.000 0.995 0.004
F64.0 Transsexualism
0.000 0.995 0.004
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.000 0.995 0.004
T46.8 Antivaricose drugs, including sclerosing agents
0.000 0.995 0.004
T46.7 Peripheral vasodilators
0.000 0.995 0.004
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.000 0.995 0.004
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.000 0.995 0.004
F00.0 Dementia in Alzheimer's disease with early onset
0.000 0.996 0.004
F64.9 Gender identity disorder, unspecified
0.000 0.996 0.004
F64.8 Other gender identity disorders
0.000 0.996 0.004
F64.2 Gender identity disorder of childhood
0.000 0.996 0.004
F64.1 Dual-role transvestism
0.000 0.996 0.004
T40.6 Other and unspecified narcotics
0.000 0.996 0.004
T45.0 Antiallergic and antiemetic drugs
0.000 0.996 0.004
H55 Nystagmus and other irregular eye movements
0.004 0.996 0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.000 0.996 0.004
T37.5 Antiviral drugs
0.000 0.996 0.004
T37.4 Anthelminthics
0.000 0.996 0.004
T37.3 Other antiprotozoal drugs
0.000 0.996 0.004
T37.2 Antimalarials and drugs acting on other blood protozoa
0.000 0.996 0.004
T37.1 Antimycobacterial drugs
0.000 0.996 0.004
T37.0 Sulphonamides
0.000 0.996 0.004
F62.9 Enduring personality change, unspecified
0.000 0.996 0.004
F62.8 Other enduring personality changes
0.000 0.996 0.004
F62.1 Enduring personality change after psychiatric illness
0.000 0.996 0.004
F62.0 Enduring personality change after catastrophic experience
0.000 0.996 0.004
F63.9 Habit and impulse disorder, unspecified
0.000 0.996 0.004
F63.8 Other habit and impulse disorders
0.000 0.996 0.004
F63.3 Trichotillomania
0.000 0.996 0.004
F63.2 Pathological stealing [kleptomania]
0.000 0.996 0.004
F63.1 Pathological fire-setting [pyromania]
0.000 0.996 0.004
F63.0 Pathological gambling
0.000 0.996 0.004
F65.9 Disorder of sexual preference, unspecified
0.000 0.996 0.004
F65.8 Other disorders of sexual preference
0.000 0.996 0.004
F65.6 Multiple disorders of sexual preference
0.000 0.996 0.004
F65.5 Sadomasochism
0.000 0.996 0.004
F65.4 Paedophilia
0.000 0.996 0.004
F65.3 Voyeurism
0.000 0.996 0.004
F65.2 Exhibitionism
0.000 0.996 0.004
F65.1 Fetishistic transvestism
0.000 0.996 0.004
F65.0 Fetishism
0.000 0.996 0.004
F66.9 Psychosexual development disorder, unspecified
0.000 0.996 0.004
F66.8 Other psychosexual development disorders
0.000 0.996 0.004
F66.2 Sexual relationship disorder
0.000 0.996 0.004
F66.1 Egodystonic sexual orientation
0.000 0.996 0.004
F66.0 Sexual maturation disorder
0.000 0.996 0.004
F68.8 Other specified disorders of adult personality and behaviour
0.000 0.996 0.004
F68.1 Intentional production or feigning of symptoms or disabilities, either physical or psychological [factitious disorder]
0.000 0.996 0.004
F68.0 Elaboration of physical symptoms for psychological reasons
0.000 0.996 0.004
T36.9 Systemic antibiotic, unspecified
0.000 0.996 0.004
T36.8 Other systemic antibiotics
0.000 0.996 0.004
T36.7 Antifungal antibiotics, systemically used
0.000 0.996 0.004
T36.6 Rifamycins
0.000 0.996 0.004
T36.5 Aminoglycosides
0.000 0.996 0.004
T36.4 Tetracyclines
0.000 0.996 0.004
T36.3 Macrolides
0.000 0.996 0.004
T36.2 Chloramphenicol group
0.000 0.996 0.004
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.000 0.996 0.004
T45.2 Vitamins, not elsewhere classified
0.000 0.996 0.004
F81.8 Other developmental disorders of scholastic skills
0.000 0.996 0.004
F81.3 Mixed disorder of scholastic skills
0.000 0.996 0.004
F81.2 Specific disorder of arithmetical skills
0.000 0.996 0.004
F81.1 Specific spelling disorder
0.000 0.996 0.004
F81.0 Specific reading disorder
0.000 0.996 0.004
T47.1 Other antacids and anti-gastric-secretion drugs
0.000 0.996 0.004
F90.9 Hyperkinetic disorder, unspecified
0.000 0.996 0.004
F90.8 Other hyperkinetic disorders
0.000 0.996 0.004
F90.1 Hyperkinetic conduct disorder
0.000 0.996 0.004
F90.0 Disturbance of activity and attention
0.000 0.996 0.004
F91.9 Conduct disorder, unspecified
0.000 0.996 0.004
F91.8 Other conduct disorders
0.000 0.996 0.004
F91.3 Oppositional defiant disorder
0.000 0.996 0.004
F91.2 Socialised conduct disorder
0.000 0.996 0.004
F91.1 Unsocialised conduct disorder
0.000 0.996 0.004
F91.0 Conduct disorder confined to the family context
0.000 0.996 0.004
F92.9 Mixed disorder of conduct and emotions, unspecified
0.000 0.996 0.004
F92.8 Other mixed disorders of conduct and emotions
0.000 0.996 0.004
F92.0 Depressive conduct disorder
0.000 0.996 0.004
F93.9 Childhood emotional disorder, unspecified
0.000 0.996 0.004
F93.8 Other childhood emotional disorders
0.000 0.996 0.004
F93.3 Sibling rivalry disorder
0.000 0.996 0.004
F93.2 Social anxiety disorder of childhood
0.000 0.996 0.004
F93.1 Phobic anxiety disorder of childhood
0.000 0.996 0.004
F93.0 Separation anxiety disorder of childhood
0.000 0.996 0.004
F94.9 Childhood disorder of social functioning, unspecified
0.000 0.996 0.004
F94.8 Other childhood disorders of social functioning
0.000 0.996 0.004
F94.2 Disinhibited attachment disorder of childhood
0.000 0.996 0.004
F94.1 Reactive attachment disorder of childhood
0.000 0.996 0.004
F94.0 Elective mutism
0.000 0.996 0.004
F95.9 Tic disorder, unspecified
0.000 0.996 0.004
F95.8 Other tic disorders
0.000 0.996 0.004
F95.2 Combined vocal and multiple motor tic disorder [de la Tourette]
0.000 0.996 0.004
F95.1 Chronic motor or vocal tic disorder
0.000 0.996 0.004
F95.0 Transient tic disorder
0.000 0.996 0.004
F98.9 Unspecified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
0.000 0.996 0.004
F98.8 Other specified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
0.000 0.996 0.004
F98.6 Cluttering
0.000 0.996 0.004
F98.5 Stuttering [stammering]
0.000 0.996 0.004
F98.4 Stereotyped movement disorders
0.000 0.996 0.004
F98.3 Pica of infancy and childhood
0.000 0.996 0.004
F98.2 Feeding disorder of infancy and childhood
0.000 0.996 0.004
F98.1 Nonorganic encopresis
0.000 0.996 0.004
F98.0 Nonorganic enuresis
0.000 0.996 0.004
T38.9 Other and unspecified hormone antagonists
0.000 0.996 0.004
T38.8 Other and unspecified hormones and their synthetic substitutes
0.000 0.996 0.004
T38.7 Androgens and anabolic congeners
0.000 0.996 0.004
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.000 0.996 0.004
T38.5 Other oestrogens and progestogens
0.000 0.996 0.004
T38.4 Oral contraceptives
0.000 0.996 0.004
T38.2 Antithyroid drugs
0.000 0.996 0.004
T38.0 Glucocorticoids and synthetic analogues
0.000 0.996 0.004
T46.4 Angiotensin-converting-enzyme inhibitors
0.000 0.996 0.004
I05.8 Other mitral valve diseases
0.004 0.996 0.000
F45 Somatoform disorders
0.000 0.996 0.004
N18 Chronic renal failure
0.000 0.996 0.004
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.996 0.004
F40.0 Agoraphobia
0.000 0.996 0.004
T46.3 Coronary vasodilators, not elsewhere classified
0.000 0.996 0.004
F23 Acute and transient psychotic disorders
0.000 0.996 0.004
S06.01 Concussion (with open intracranial wound)
0.004 0.996 0.000
F44.9 Dissociative [conversion] disorder, unspecified
0.000 0.996 0.004
M54.1 Radiculopathy
0.004 0.996 0.000
S06 Intracranial injury
0.004 0.996 0.000
F10 Mental and behavioural disorders due to use of alcohol
0.000 0.996 0.004
F00.1 Dementia in Alzheimer's disease with late onset
0.000 0.996 0.004
H54.0 Blindness, both eyes
0.000 0.996 0.004
F60.3 Emotionally unstable personality disorder
0.000 0.996 0.004
S06.80 Other intracranial injuries (without open intracranial wound)
0.004 0.996 0.000
H54.1 Blindness, one eye, low vision, other eye
0.000 0.996 0.004
S06.8 Other intracranial injuries
0.004 0.996 0.000
T38.1 Thyroid hormones and substitutes
0.000 0.996 0.004
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.000 0.996 0.004
M54.64 Pain in thoracic spine (Thoracic region)
0.004 0.996 0.000
F41 Other anxiety disorders
0.000 0.996 0.004
F23.9 Acute and transient psychotic disorder, unspecified
0.000 0.996 0.004
H54.2 Low vision, both eyes
0.000 0.996 0.004
F50.0 Anorexia nervosa
0.000 0.996 0.004
F05 Delirium, not induced by alcohol and other psychoactive substances
0.000 0.996 0.004
M54.18 Radiculopathy (Sacral and sacrococcygeal region)
0.004 0.996 0.000
H54.3 Unqualified visual loss, both eyes
0.000 0.996 0.004
K86.3 Pseudocyst of pancreas
0.000 0.996 0.004
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.000 0.996 0.004
F41.0 Panic disorder [episodic paroxysmal anxiety]
0.000 0.996 0.004
F50.8 Other eating disorders
0.000 0.996 0.004
F50.5 Vomiting associated with other psychological disturbances
0.000 0.996 0.004
F50.4 Overeating associated with other psychological disturbances
0.000 0.996 0.004
F50.3 Atypical bulimia nervosa
0.000 0.996 0.004
F50.2 Bulimia nervosa
0.000 0.996 0.004
F50.1 Atypical anorexia nervosa
0.000 0.996 0.004
F51.9 Nonorganic sleep disorder, unspecified
0.000 0.996 0.004
F51.8 Other nonorganic sleep disorders
0.000 0.996 0.004
F51.5 Nightmares
0.000 0.996 0.004
F51.4 Sleep terrors [night terrors]
0.000 0.996 0.004
F51.3 Sleepwalking [somnambulism]
0.000 0.996 0.004
F51.2 Nonorganic disorder of the sleep-wake schedule
0.000 0.996 0.004
F51.1 Nonorganic hypersomnia
0.000 0.996 0.004
F51.0 Nonorganic insomnia
0.000 0.996 0.004
F53.9 Puerperal mental disorder, unspecified
0.000 0.996 0.004

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.